指南与共识复苏、休克与脓毒症心脑血管急症儿科与产科急症

儿童院外心脏骤停自主循环恢复后目标温度管理策略:GRADE评估的系统评价与Meta分析

Targeted Temperature Management Strategies in Pediatric Patients with Return of Spontaneous Circulation after Out-of-Hospital Cardiac Arrest: A Grading of Recommendations, Assessment, Development, and Evaluation-Assessed Systematic Review and Meta-Analysis.
指南 / 共识 · Ther Hypothermia Temp Manag · 2025-09-16
一句话结论儿童院外心脏骤停自主循环恢复后,治疗性低温与常温相比与更高的生存率和有利神经结局相关,但证据确定性低。

该系统评价与Meta分析纳入9项研究共2107例儿童院外心脏骤停患者,评估不同目标温度管理策略对生存和神经结局的影响。治疗性低温与常温相比,生存的比值比OR为1.72(95%CI 1.36-2.18,p<0.0001),有利神经结局的OR为1.64(95%CI 1.16-2.33,p=0.006)。亚组分析显示12个月时生存获益更大,6-12个月时神经结局改善。两组在血乳酸水平、心律失常几率、培养证实的感染或住院时间方面无统计学显著差异。大多数结局的证据确定性因非随机研究为主和不精确性而被评为低。

要点

  • 儿童院外心脏骤停自主循环恢复后,治疗性低温与常温相比,生存OR为1.72(95%CI 1.36-2.18,p<0.0001)。
  • 治疗性低温与常温相比,有利神经结局OR为1.64(95%CI 1.16-2.33,p=0.006)。
  • 亚组分析显示12个月时生存获益更大,6-12个月时神经结局改善。
  • 两组在血乳酸水平、心律失常几率、培养证实的感染或住院时间方面无统计学显著差异。
  • 大多数结局的证据确定性被评为低,主要因非随机研究为主和不精确性。

适用人群与场景

  • 儿童院外心脏骤停后自主循环恢复的患者,共9项研究2107例。

研究设计与关键结果

  • 系统评价与Meta分析纳入9项研究共2107例儿童院外心脏骤停患者,比较治疗性低温与常温。
  • 治疗性低温与常温相比,生存OR为1.72(95%CI 1.36-2.18,p<0.0001)。
  • 治疗性低温与常温相比,有利神经结局OR为1.64(95%CI 1.16-2.33,p=0.006)。
  • 亚组分析显示12个月时生存获益更大,6-12个月时神经结局改善。
  • 两组在血乳酸水平、心律失常几率、培养证实的感染或住院时间方面无统计学显著差异。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,采用GRADE方法评估证据确定性。
  • 大多数结局的证据确定性被评为低,主要因非随机研究为主和不精确性。
  • 局限:原文指出证据确定性低,需要进一步高质量随机试验以指导临床实践和优化神经保护治疗。

对床旁实践的改变

  • 作者认为,治疗性低温作为儿童院外心脏骤停后的目标温度管理策略可能提供生存和神经获益,尤其在较长随访时,且不良事件无显著增加。
  • 原文指出证据确定性低,强调需要进一步高质量随机试验以指导临床实践。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Out-of-hospital cardiac arrest (OHCA) in children is a rare but catastrophic event, often resulting in significant neurological injury. Targeted temperature management (TTM), including therapeutic hypothermia (TH), has been proposed as a neuroprotective strategy. This systematic review and meta-analysis aims to evaluate the effects of different TTM strategies on survival and neurological outcomes in pediatric patients after OHCA. A comprehensive literature search was conducted across PubMed, Scopus, Web of Science, Embase, and the Cochrane Library. Pooled outcomes were synthesized using odds ratios (OR) with 95% confidence intervals (CI), and the certainty of evidence was appraised using the Grading of Recommendations, Assessment, Development, and Evaluation approach. A total of nine studies encompassing 2107 pediatric patients were included. TH was associated with significantly higher odds of survival (OR: 1.72; 95% CI: 1.36-2.18; p < 0.0001) and favorable neurological outcome (OR: 1.64; 95% CI: 1.16-2.33; p = 0.006) compared to normothermia. Subgroup analysis demonstrated greater survival benefit at 12 months and improved neurological outcomes at 6-12 months. There were no statistically significant differences between groups in blood lactate levels, odds of arrhythmia, culture-proven infections, or length of hospital stay. The certainty of evidence for most outcomes was graded as low due to the predominance of nonrandomized studies and imprecision. TH as a TTM strategy following pediatric OHCA may offer survival and neurological advantage, particularly at longer-term follow-up, without a significant increase in adverse events. However, the low certainty of evidence highlights the need for further high-quality randomized trials to inform clinical practice and optimize neuroprotective care in this vulnerable population.

来源:Ther Hypothermia Temp Manag,查看原文。版权归原作者所有。

参考来源

  1. Alsabri M, Rath S, Kamal I, et al. Targeted Temperature Management Strategies in Pediatric Patients with Return of Spontaneous Circulation after Out-of-Hospital Cardiac Arrest: A Grading of Recommendations, Assessment, Development, and Evaluation-Assessed Systematic Review and Meta-Analysis. Ther Hypothermia Temp Manag. 2025. PMID: 40956682. doi:10.1177/21537658251379156

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。